The official blog of the Lung Institute.

This Week in Lung Disease: Wildfires Continue in California

31 Jul 2016
| Under Lifestyle | Posted by | 4 Comments
lung disease news

The internet is a big place and sometimes it can be difficult to find the news about the things that concern you. That’s why each week, the Lung Institute searches the internet to find the latest lung disease news. That way, you don’t have to waste time and can focus on your family and health.

Wildfires Continue in California

Brush fires in the Santa Clarita Valley have grown by more than 10,000 acres last weekend. The fires, happening in the mountains north of Los Angeles, have scored an estimated 33,172 acres. Mandatory evacuations have affected about 1,500 residents in nearby areas.

For those with chronic lung disease, wildfire smoke can be very hazardous. If a wildfire is happening in your region, make sure to follow the local news for air quality updates so you can be better prepared when leaving the house.

Read more about this story by going to the Los Angeles Times’ website.

Nearby Fracking May Worsen Symptoms of Asthma

A recent study conducted in Pennsylvania found that asthma for children and adults may have worsened for those living near fracking sites.

Fracking is a drilling technique for extracting oil and gas by injecting water and other materials into wells at high pressure to crack rocks. The environmental side effects of fracking have been a hot topic of debate in recent years. The study found that asthma treatments were up to four times more common for people living near bigger, more active wells than people who didn’t.

However, the study doesn’t say that fracking directly caused or worsened asthma.

To read more about this story, go to NBC News’ website.

Stem Cell Trial Suggests Hope for Those with Heart Disease

A recent small-scale study suggests damaged heart tissue could be regenerated thought a stem cell treatment during heart surgery. The study, published in the Journal of Cardiovascular Translational Research, included 11 patients who received a stem cell injection into their hearts during a bypass.

Another notable finding was a 40 percent reduction in the size of scarred tissue. Previous to this study, it was thought that scarred tissue in the lungs was irreversible. More research is needed.

To find out more about this story, go to The Guardian.

Hip Replacements Could Be Thing of the Past Due to Stem Cells

Scientists have been trying new methods of growing new joint cartilage in an effort to change the way we treat damaged joints. This research, being conducted at the Washington University School of Medicine in St. Louis, looks to be a major step toward being able to use a patient’s own cells to repair joint injuries and do away with joint replacement surgeries. Scientists coaxed stem cells to grow new cartilage on a scaffold shaped like the ball of a hip joint.

For more information, go to Live Science.

Keep checking in with us for the latest lung disease news. If you or someone you know has a chronic lung disease, remember there is hope. At the Lung Institute, we specialize in stem cell treatments for those with lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. For more information about the Lung Institute or stem cell therapy, please contact one of our patient coordinators by calling (800) 729-3065 today.


  1. PB

    2 years ago

    Dear Karen,

    Thanks for your question. The Lung Institute has treated patients in a variety of COPD stages, including stage 4 COPD. Unfortunately, at this time, insurance companies don’t cover treatment. However, we’re hopeful that treatment will be covered by insurance companies in the near future. Keep in mind that it will take some time before the insurance companies see a financial benefit in their favor and then decide to cover it. In the meantime, you can learn more about stem cell treatment options and have your questions answered by one of our patient coordinators. Feel free to contact us at (855) 313-1149 for more information. We look forward to hearing from you soon.

    Kind Regards,

    The Lung Institute

  2. Karen campbell

    2 years ago

    Do you have a list of which medical cover your treatments and do you help people who are stage 4 c.o.p.d. and have had a pneamothorx .

  3. PB

    2 years ago

    Dear Adeline,

    Thanks for your question. While the Lung Institute doesn’t treat people with MS, we did some research and found this interesting article about stem cell therapy for MS. You can read the article by clicking here. We hope this is helpful information for you, and we wish you the best.

    Kind Regards,

    The Lung Institute

  4. Adeline Murray

    2 years ago

    Is there any stem cell research progress for MS??

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.